NeoGenomics, Inc. (NEO)
13.16
+0.33
(+2.57%)
USD |
NASDAQ |
Jan 09, 16:00
13.18
+0.02
(+0.11%)
After-Hours: 20:00
NeoGenomics EPS Diluted (Quarterly): -0.2113 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| IQVIA Holdings, Inc. | 1.928 |
| Incyte Corp. | 2.106 |
| Regeneron Pharmaceuticals, Inc. | 13.62 |
| Arcturus Therapeutics Holdings, Inc. | -0.4946 |
| Fortrea Holdings, Inc. | -0.1743 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -27.13M |
| Revenue (Quarterly) | 187.80M |
| Total Expenses (Quarterly) | 214.93M |
| Enterprise Value | 1.949B |
| Gross Profit Margin (Quarterly) | 41.23% |
| Profit Margin (Quarterly) | -14.45% |
| Earnings Yield | -6.75% |
| Normalized Earnings Yield | -5.138 |